The long legal battle between pharmaceutical firm Allergan Inc. and [Athena Cosmetics Inc.] could be coming to a head, as what began as a patent dispute between the competing eyelash-enhancement marketers may now have the Supreme Court deciding whether drug/cosmetic debates are a matter of state or federal authority.
Athena has petitioned the Supreme Court to review a lower court’s decision that its RevitaLash eyelash-enhancement formulas are drugs as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?